Skip to main content
OpenTrials
Completed

NCT Number: NCT02783807

Clinical Equivalency Validation Protocol Clinical Equivalency Eyenez Retina Camera v200 and Optomed Smartscope M5 EY3

This prospective equivalency study compares the performance of two Ophthalmic Cameras, the Eyenez Retina Ophthalmic Camera v200 (OC) and the Optomed Smartscope M5 EY3 (OP). Trained technicians will take pictures of the same patients' retinas and the quality of the photos will be evaluated. The study includes healthy patients and patients with a spectrum of retinal diseases. The study requires that technicians take pictures of the retinas of adult patients between 18 and 80 years of age using both the OC and OP. The pictures will be reviewed and compared by a central reader/Ophthalmologist, who will determine if the OC is equivalent to the OP, based on the quality of the images

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Subjects (patients) will be recruited via word of mouth.

The study duration will be approximately 1-2 weeks, assuming a recruitment rate of 15 subjects per week. The images will be recorded within 15 minutes and will involve minimal disruption to the clinical workflow.

In the Study Environment setting (Foothill Medical Offices), the User Interface will be evaluated by comparing retinal pictures taken with subject device OC and predicate device OP.

Patient subjects will be given an Information and Consent Form to complete prior to the study

The technicians employed by Foothill Eye Clinic will operate the device on patient participants by taking a retinal picture using OC.

The technicians will use the predicate device OP to take retinal pictures.

The Ophthalmologist will compare the results with the pictures taken by OC and OP. The Ophthalmologist will be blinded to what picture was taken by which camera and record his assessment of the quality for each picture.

Patient subjects will receive a standard of care exam with or without dilation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Healthy subjects Inclusion Criteria:

  • Written Informed Consent
  • Male or female
  • Age ≥ 18 years and ≤80 years
  • Normal Retina

Healthy subjects Exclusion Criteria:

  • Glaucoma
  • Limited Ability for Agreement
  • Spectrum of retinal diseases
  • Subjects that may have been exposed to retinal photography in the past 24 hours prior to the study visit or plan to have retinal photography in the 24 hours after the study visit

Diseased subjects Inclusion Criteria:

  • Written Informed Consent
  • Male or female
  • Age ≥ 18 years and ≤80 years
  • Spectrum of retinal diseases

Diseased subjects Exclusion Criteria:

  • Normal Retina
  • Limited Ability for Agreement
  • Subjects that may have been exposed to retinal photography in the past 24 hours prior to the study visit or plan to have retinal photography in the 24 hours after the study visit

Treatment and study plan

Eyenez Retinal Camera v200

Device

Volk Pictor Ret 1

Device

Other names: Optimed Smartscope M5 EY3

Primary outcomes

  1. Clinical Evaluation of Retina Camera Images from both Healthy and Diseased Subjects

    Time frame: up to 1 week

    At least 90% of retinal camera images from both retinal cameras will be equivalent

Sponsors and collaborators

Lead sponsor

Eyenez LLC

Industry

Registry information

Official study title

Clinical Equivalency Validation Protocol Eyenez v200 and Volk Pictor Ret1

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
May 26, 2016
Registry last updated
May 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.